OTCMKTS:AVMXYAVITA MED LTD/S Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding AVITA MED LTD/S Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $7.89 0.00 (0.00 %) (As of 11/27/2019) Add Compare Share Today's Range$7.89Now: $7.89▼$7.8950-Day Range$7.89MA: $7.89▼$7.8952-Week Range$1.06Now: $7.89▼$8.58VolumeN/AAverage Volume183,275 shsMarket Capitalization$651.87 millionP/E RatioN/ADividend YieldN/ABeta1.28 ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingAVITA MED LTD/S has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $10.00, AVITA MED LTD/S has a potential upside of 26.7% from its current price of $7.89.Amount of Analyst CoverageAVITA MED LTD/S has received no research coverage in the past 90 days. Previous Next 2.8 Community Rank Outperform VotesAVITA MED LTD/S has received 140 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAVITA MED LTD/S has received 109 “underperform” votes. (Add your “underperform” vote.)Community SentimentAVITA MED LTD/S has received 56.22% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about AVITA MED LTD/S and other stocks. Vote “Outperform” if you believe AVMXY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AVMXY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAVITA MED LTD/S does not currently pay a dividend.Dividend GrowthAVITA MED LTD/S does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AVITA MED LTD/S insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.01% of the stock of AVITA MED LTD/S is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for AVITA MED LTD/S are expected to grow in the coming year, from ($0.41) to $0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AVITA MED LTD/S is -20.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AVITA MED LTD/S is -20.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAVITA MED LTD/S has a P/B Ratio of 30.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.39 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:AVMXY Previous Symbol CUSIPN/A CIKN/A Webwww.avitamedical.com Phone661-367-9170Debt Debt-to-Equity RatioN/A Current Ratio5.50 Quick Ratio5.33Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5.51 million Price / Sales118.31 Cash FlowN/A Price / Cash FlowN/A Book Value$0.26 per share Price / Book30.35Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees55 Outstanding Shares82,620,000Market Cap$651.87 million Next Earnings DateN/A OptionableNot Optionable OTC:AVMXY Rates by TradingView Receive AVMXY News and Ratings via Email Sign-up to receive the latest news and ratings for AVMXY and its competitors with MarketBeat's FREE daily newsletter. AVITA MED LTD/S (OTCMKTS:AVMXY) Frequently Asked Questions How has AVITA MED LTD/S's stock been impacted by COVID-19 (Coronavirus)? AVITA MED LTD/S's stock was trading at $7.89 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AVMXY shares have increased by 0.0% and is now trading at $7.89. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of AVITA MED LTD/S? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AVITA MED LTD/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AVITA MED LTD/S. What price target have analysts set for AVMXY? 1 brokerages have issued 1-year target prices for AVITA MED LTD/S's stock. Their forecasts range from $10.00 to $10.00. On average, they expect AVITA MED LTD/S's stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 26.7% from the stock's current price. View analysts' price targets for AVITA MED LTD/S. Has AVITA MED LTD/S been receiving favorable news coverage? Press coverage about AVMXY stock has been trending very positive on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. AVITA MED LTD/S earned a news sentiment score of 3.5 on InfoTrie's scale. They also assigned press coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutAVITA MED LTD/S. Who are some of AVITA MED LTD/S's key competitors? Some companies that are related to AVITA MED LTD/S include Alector (ALEC), Fate Therapeutics (FATE), Bill.com (RVMD), Sangamo Therapeutics (SGMO), SpringWorks Therapeutics (SWTX), Adverum Biotechnologies (ADVM), Twist Bioscience (TWST), Mesoblast (MESO), Editas Medicine (EDIT), Adaptimmune Therapeutics (ADAP), I-Mab (BDTX), Regenxbio (RGNX), Cortexyme (CRTX), Coherus Biosciences (CHRS) and Beam Therapeutics (BEAM). View all competitors. Who are AVITA MED LTD/S's key executives? AVITA MED LTD/S's management team includes the following people: Dr. Michael S. Perry, CEO & Director (Age 60)Mr. Timothy Rooney, Chief Admin. Officer & Interim CFOMr. Andrew Quick, Chief Technology OfficerMs. Erin Liberto, Chief Commercial OfficerMr. Adam Kelliher, Consultant What is AVITA MED LTD/S's stock symbol? AVITA MED LTD/S trades on the OTCMKTS under the ticker symbol "AVMXY." How do I buy shares of AVITA MED LTD/S? Shares of AVMXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is AVITA MED LTD/S's stock price today? One share of AVMXY stock can currently be purchased for approximately $7.89. How big of a company is AVITA MED LTD/S? AVITA MED LTD/S has a market capitalization of $651.87 million and generates $5.51 million in revenue each year. The medical device company earns $-24,750,000.00 in net income (profit) each year or ($0.39) on an earnings per share basis. AVITA MED LTD/S employs 55 workers across the globe. What is AVITA MED LTD/S's official website? The official website for AVITA MED LTD/S is www.avitamedical.com. How can I contact AVITA MED LTD/S? AVITA MED LTD/S's mailing address is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. The medical device company can be reached via phone at 661-367-9170 or via email at [email protected] This page was last updated on 6/2/2020 by MarketBeat.com Staff
